NFKB1 and B-cell chronic lymphocytic leukemia: The function of the NF-κB signaling pathway in the proliferation and apoptosis of chronic lymphocytic leukemia (CLL) cells is a hotspot in cancer research and is therefore considered a promising therapeutic target for the treatment of CLL (2).